ShapeTX Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
85
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$112M
- Investors
-
12
ShapeTX General Information
Description
Developer of programmable RNA medicines designed to repair the genetic causes of disease. The company offers AI-powered RNA design, precise tissue targeting, and scalable manufacturing technologies, enabling researchers and healthcare providers to create safe, effective, and customizable RNA therapies for a broad range of genetic conditions.
Contact Information
Website
www.shapetx.comCorporate Office
- 700 Dexter Avenue North
- Seattle, WA 98109
- United States
Corporate Office
- 700 Dexter Avenue North
- Seattle, WA 98109
- United States
ShapeTX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 15-Jul-2021 | $112M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 27-Aug-2019 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-May-2018 | Completed | Startup |
ShapeTX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 44,999,982 | $0.000100 | 8% | $0.67 | $0.67 | 1x | $0.67 | 17.3% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ShapeTX Comparisons
Industry
Financing
Details
ShapeTX Competitors (8)
One of ShapeTX’s 8 competitors is Affinia Therapeutics, a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Affinia Therapeutics | Venture Capital-Backed | Waltham, MA | ||||
| Capsigen | Venture Capital-Backed | Vancouver, WA | ||||
| Capsida Biotherapeutics | Venture Capital-Backed | Thousand Oaks, CA | ||||
| WaVe Life Sciences | Formerly VC-backed | Cambridge, MA | ||||
| Korro Bio | Formerly VC-backed | Cambridge, MA |
ShapeTX Patents
ShapeTX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026193218-A1 | Capsid mutations for aav production | Pending | 12-Mar-2025 | ||
| WO-2026073032-A1 | Constructs for improved aav production | Pending | 27-Sep-2024 | ||
| WO-2026060273-A1 | 5' untranslated regions (utrs) for enhanced payload expression | Pending | 13-Sep-2024 | ||
| WO-2026044087-A1 | Increased cellular stability for aav production | Pending | 21-Aug-2024 | ||
| WO-2026036118-A1 | Engineered aav capsid polypeptides and methods of use | Pending | 09-Aug-2024 | C07K14/005 |
ShapeTX Signals
ShapeTX Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cherubic Ventures | Venture Capital | Minority | ||
| Decheng Capital | Venture Capital | Minority | ||
| Willett Advisors | Family Office | Minority | ||
| Breton Capital Ventures | Venture Capital | Minority | ||
| CureDuchenne Ventures | Corporate Venture Capital | Minority |
ShapeTX FAQs
-
When was ShapeTX founded?
ShapeTX was founded in 2018.
-
Where is ShapeTX headquartered?
ShapeTX is headquartered in Seattle, WA.
-
What is the size of ShapeTX?
ShapeTX has 85 total employees.
-
What industry is ShapeTX in?
ShapeTX’s primary industry is Drug Discovery.
-
Is ShapeTX a private or public company?
ShapeTX is a Private company.
-
What is the current valuation of ShapeTX?
The current valuation of ShapeTX is .
-
What is ShapeTX’s current revenue?
The current revenue for ShapeTX is .
-
How much funding has ShapeTX raised over time?
ShapeTX has raised $148M.
-
Who are ShapeTX’s investors?
Cherubic Ventures, Decheng Capital, Willett Advisors, Breton Capital Ventures, and CureDuchenne Ventures are 5 of 12 investors who have invested in ShapeTX.
-
Who are ShapeTX’s competitors?
Affinia Therapeutics, Capsigen, Capsida Biotherapeutics, WaVe Life Sciences, and Korro Bio are some of the 8 competitors of ShapeTX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process